$FMHS
FARMHOUSE, INC. /NV Stock $fmhs

$fmhs Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-K Financial Statement

#000109690623000882 Filed on April 20, 2023

Income Statement

Concept	2023 Q2	2022 Q4	2022
Revenue	$4.134K	$2.640K	$10.26K
YoY Change	56.06%	1220.0%	-16.17%
Cost Of Revenue	$2.066K	$1.320K	$3.806K
YoY Change		-83.5%	-52.43%
Gross Profit	$2.068K	$1.320K	$6.455K
YoY Change	-21.93%	-116.92%	52.24%
Gross Profit Margin	50.02%	50.0%	62.91%
Selling, General & Admin	$142.7K	$141.1K	$785.7K
YoY Change	-42.78%	-58.47%	-19.29%
% of Gross Profit	6899.9%	10690.15%	12172.58%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$0.00	$0.00	$94.00
YoY Change		-100.0%	-92.03%
% of Gross Profit	0.0%	0.0%	1.46%
Operating Expenses	$142.7K	$141.1K	$786.1K
YoY Change	-42.78%	-58.5%	-19.35%
Operating Profit	-$140.6K	-$139.8K	-$779.6K
YoY Change	-43.01%	-59.81%	-19.66%
Interest Expense	$12.45K	$212.6K	$53.15K
YoY Change	33.38%	-2331.06%	-227.27%
% of Operating Profit
Other Income/Expense, Net	-$12.45K	$0.00	$336.9K
YoY Change	33.38%		1405.14%
Pretax Income	-$153.1K	$72.58K	-$442.8K
YoY Change	-40.22%	-120.31%	-54.61%
Income Tax			$0.00
% Of Pretax Income
Net Earnings	-$153.1K	$72.58K	-$442.8K
YoY Change	-40.22%	-120.31%	-54.61%
Net Earnings / Revenue	-3702.88%	2749.24%	-4315.19%
Basic Earnings Per Share
Diluted Earnings Per Share	-$0.01	$0.00	-$0.03
COMMON SHARES
Basic Shares Outstanding	17.08M shares	17.05M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2023 Q2	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$7.810K	$62.06K	$62.06K
YoY Change		1541.8%	1541.8%
Cash & Equivalents	$7.814K	$62.06K	$62.06K
Short-Term Investments
Other Short-Term Assets	$3.990K	$3.810K	$3.810K
YoY Change	4.72%	1.6%	1.6%
Inventory
Prepaid Expenses	$3.990K	$3.810K
Receivables	$5.203K	$0.00
Other Receivables	$0.00
Total Short-Term Assets	$17.01K	$65.87K	$65.87K
YoY Change	346.38%	774.81%	774.77%
LONG-TERM ASSETS
Property, Plant & Equipment		$0.00	$0.00
YoY Change		-100.0%	-100.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$0.00	$0.00	$0.00
YoY Change	-100.0%	-100.0%	-100.0%
TOTAL ASSETS
Total Short-Term Assets	$17.01K	$65.87K	$65.87K
Total Long-Term Assets	$0.00	$0.00	$0.00
Total Assets	$17.01K	$65.87K	$65.87K
YoY Change	318.89%	736.59%	736.98%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$25.51K	$11.18K	$11.18K
YoY Change	28.89%	17.69%	17.68%
Accrued Expenses	$180.1K	$156.1K	$1.499M
YoY Change	31.38%	54.82%	16.05%
Deferred Revenue
YoY Change
Short-Term Debt	$95.00K	$95.00K	$95.00K
YoY Change	-25.58%	-20.85%	-20.85%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$1.784M	$1.650M	$1.650M
YoY Change	1.03%	4.48%	4.48%
LONG-TERM LIABILITIES
Long-Term Debt	$25.00K	$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$25.00K	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.784M	$1.650M	$1.650M
Total Long-Term Liabilities	$25.00K	$0.00	$0.00
Total Liabilities	$1.809M	$1.650M	$1.650M
YoY Change	2.45%	4.48%	4.48%
SHAREHOLDERS EQUITY
Retained Earnings	-$6.069M	-$5.745M
YoY Change	4.78%	8.35%
Common Stock	$1.708K	$1.708K
YoY Change	7.02%	8.79%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$1.792M	-$1.584M	-$1.584M
YoY Change
Total Liabilities & Shareholders Equity	$17.01K	$65.87K	$65.87K
YoY Change	318.89%	736.59%	736.98%

Cashflow Statement

Concept	2023 Q2	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	-$153.1K	$72.58K	-$442.8K
YoY Change	-40.22%	-120.31%	-54.61%
Depreciation, Depletion And Amortization	$0.00	$0.00	$94.00
YoY Change		-100.0%	-92.03%
Cash From Operating Activities	-$21.82K	-$10.15K	-$252.8K
YoY Change	-4.05%	-81.94%	20.25%
INVESTING ACTIVITIES
Capital Expenditures		$0.00	$0.00
YoY Change		-100.0%	-100.0%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$225.0K	$390.0K
YoY Change
Cash From Investing Activities	$0.00	$225.0K	$390.0K
YoY Change		-90100.0%	-156100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$59.42K
YoY Change			-53.4%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	20.96K	-268.9K	-$78.92K
YoY Change	-4.34%	-1864.44%	-137.52%
NET CHANGE
Cash From Operating Activities	-21.82K	-10.15K	-$252.8K
Cash From Investing Activities	0.000	225.0K	$390.0K
Cash From Financing Activities	20.96K	-268.9K	-$78.92K
Net Change In Cash	-860.0	-54.05K	$58.28K
YoY Change	3.61%	31.16%	-48669.17%
FREE CASH FLOW
Cash From Operating Activities	-$21.82K	-$10.15K	-$252.8K
Capital Expenditures		$0.00	$0.00
Free Cash Flow		-$10.15K	-$252.8K
YoY Change		-81.86%	20.39%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	333-238326
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	46-3321759
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	548 Market Street
CY2022	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 90355
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	San Francisco
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	94104
CY2022	dei	Entity Address Address Description EntityAddressAddressDescription	Address of principal executive offices
CY2022	dei	Phone Fax Number Description PhoneFaxNumberDescription	Registrant’s telephone number
CY2022	dei	City Area Code CityAreaCode	888
CY2022	dei	Local Phone Number LocalPhoneNumber	420-6856
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Public Float EntityPublicFloat	699294	usd
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	17075950	shares
CY2022	dei	Auditor Firm AuditorFirmId	6258
CY2022	dei	Auditor Name AuditorName	Mac Accounting Group & CPAs, LLP
CY2022	dei	Auditor Location AuditorLocation	Midvale, Utah
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	62063	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3780	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	3810	usd
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	3750	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	65873	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	7530	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	0	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	94	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	0	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	250	usd
CY2022Q4	us-gaap	Assets Assets	65873	usd
CY2021Q4	us-gaap	Assets Assets	7874	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	11181	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	9500	usd
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	348137	usd
CY2021Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	391067	usd
CY2022Q4	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	945608	usd
CY2021Q4	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	761463	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	156050	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	100796	usd
CY2022Q4	us-gaap	Interest Payable Current InterestPayableCurrent	48931	usd
CY2021Q4	us-gaap	Interest Payable Current InterestPayableCurrent	38070	usd
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	45000	usd
CY2021Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	45000	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	50000	usd
CY2021Q4	us-gaap	Notes Payable Current NotesPayableCurrent	75030	usd
CY2022Q4	fil	Due To Related Parties DueToRelatedParties	44882	usd
CY2021Q4	fil	Due To Related Parties DueToRelatedParties	158191	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1649789	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1579117	usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	295000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	295000000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	17075950	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	17075950	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	15694550	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	15694550	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	1708	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	1570	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	4159075	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	3729104	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-5744699	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-5301917	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-1583916	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-1571243	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	65873	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	7874	usd
CY2022	fil	Net Revenues NetRevenues	10261	usd
CY2021	fil	Net Revenues NetRevenues	12243	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	3806	usd
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	8000	usd
CY2022	us-gaap	Gross Profit GrossProfit	6455	usd
CY2021	us-gaap	Gross Profit GrossProfit	4243	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	403372	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	451012	usd
CY2022	us-gaap	Professional Fees ProfessionalFees	382371	usd
CY2021	us-gaap	Professional Fees ProfessionalFees	522476	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	94	usd
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1178	usd
CY2022	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	250	usd
CY2021	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	786087	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	974666	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-779632	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-970423	usd
CY2022	fil	Recovery Of Expense In Litigation RecoveryOfExpenseInLitigation	0	usd
CY2021	fil	Recovery Of Expense In Litigation RecoveryOfExpenseInLitigation	22382	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	14220	usd
CY2022	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	165000	usd
CY2021	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	0	usd
CY2022	us-gaap	Net Investment Income NetInvestmentIncome	225000	usd
CY2021	us-gaap	Net Investment Income NetInvestmentIncome	0	usd
CY2022	us-gaap	Interest Expense InterestExpense	53150	usd
CY2021	us-gaap	Interest Expense InterestExpense	41758	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	336850	usd
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-5156	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-442782	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-975579	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-442782	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-975579	usd
CY2022	fil	Basic And Diluted Net Loss Per Share BasicAndDilutedNetLossPerShare	-0.03
CY2021	fil	Basic And Diluted Net Loss Per Share BasicAndDilutedNetLossPerShare	-0.06
CY2022	fil	Basic And Diluted Weighted Average Number Of Shares Outstanding BasicAndDilutedWeightedAverageNumberOfSharesOutstanding	16376154	shares
CY2021	fil	Basic And Diluted Weighted Average Number Of Shares Outstanding BasicAndDilutedWeightedAverageNumberOfSharesOutstanding	15217653	shares
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-1135712	usd
CY2021	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	127500	usd
CY2021	fil	Common Stock Issued For Anti Dilution Protection CommonStockIssuedForAntiDilutionProtection	0	usd
CY2021	fil	Common Stock Issued For Restricted Stock Awards CommonStockIssuedForRestrictedStockAwards	0	usd
CY2021	fil	Stock Based Compensation On Rsa S Vested StockBasedCompensationOnRsaSVested	51000	usd
CY2022	fil	Common Stock Issued For Settlement Of Liabilities CommonStockIssuedForSettlementOfLiabilities	15780	usd
CY2021	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	345768	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-975579	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-1571243	usd
CY2022	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	59415	usd
CY2022	fil	Common Stock Issued For Restricted Stock Awards CommonStockIssuedForRestrictedStockAwards	0	usd
CY2022	fil	Stock Based Compensation On Rsa S Vested StockBasedCompensationOnRsaSVested	181112	usd
CY2022	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	189582	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-442782	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-1583916	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-442782	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-975579	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	94	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1178	usd
CY2022	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	189582	usd
CY2021	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	345768	usd
CY2022	fil	Stock Based Compensation On Rsa S Vested StockBasedCompensationOnRsaSVested	181112	usd
CY2021	fil	Stock Based Compensation On Rsa S Vested StockBasedCompensationOnRsaSVested	51000	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	14220	usd
CY2022	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	250	usd
CY2021	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	0	usd
CY2022	us-gaap	Increase Decrease In Accrued Investment Income Receivable IncreaseDecreaseInAccruedInvestmentIncomeReceivable	225000	usd
CY2021	us-gaap	Increase Decrease In Accrued Investment Income Receivable IncreaseDecreaseInAccruedInvestmentIncomeReceivable	0	usd
CY2022	us-gaap	Gain Loss On Disposition Of Intangible Assets GainLossOnDispositionOfIntangibleAssets	165000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	60	usd
CY2021	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	3750	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1681	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1471	usd
CY2022	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	-42930	usd
CY2021	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	123940	usd
CY2022	us-gaap	Increase Decrease In Accrued Salaries IncreaseDecreaseInAccruedSalaries	184145	usd
CY2021	us-gaap	Increase Decrease In Accrued Salaries IncreaseDecreaseInAccruedSalaries	184142	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	55254	usd
CY2021	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	71785	usd
CY2022	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	0	usd
CY2021	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-3000	usd
CY2022	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	10861	usd
CY2021	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	9975	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-252793	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-210232	usd
CY2022	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	0	usd
CY2021	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	250	usd
CY2022	us-gaap	Proceeds From Sales Of Assets Investing Activities ProceedsFromSalesOfAssetsInvestingActivities	165000	usd
CY2021	us-gaap	Proceeds From Sales Of Assets Investing Activities ProceedsFromSalesOfAssetsInvestingActivities	0	usd
CY2022	fil	Settlement From Equity Security Investment SettlementFromEquitySecurityInvestment	225000	usd
CY2021	fil	Settlement From Equity Security Investment SettlementFromEquitySecurityInvestment	0	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	390000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-250	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	59415	usd
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	127500	usd
CY2022	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	7620	usd
CY2021	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	75030	usd
CY2022	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	32650	usd
CY2021	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	0	usd
CY2022	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	0	usd
CY2021	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	24620	usd
CY2022	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	113309	usd
CY2021	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	16794	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-78924	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	210356	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	58283	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-126	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3780	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3906	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	62063	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3780	usd
CY2022	us-gaap	Interest Paid InterestPaid	1253	usd
CY2021	us-gaap	Interest Paid InterestPaid	1937	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2022	fil	Common Stock Issued For Extinguishment Of Debt CommonStockIssuedForExtinguishmentOfDebt	0	usd
CY2021	fil	Common Stock Issued For Extinguishment Of Debt CommonStockIssuedForExtinguishmentOfDebt	15780	usd
CY2022	fil	Common Stock Issued For Anti Dilution Protection1 CommonStockIssuedForAntiDilutionProtection1	0	usd
CY2021	fil	Common Stock Issued For Anti Dilution Protection1 CommonStockIssuedForAntiDilutionProtection1	4	usd
CY2022	us-gaap	Nature Of Operations NatureOfOperations	<p style="font:10pt Times New Roman;margin-top:0pt;margin-bottom:8pt;margin-right:-1.8pt;text-align:justify"><b>NOTE 1 – ORGANIZATION AND OPERATIONS</b></p> <p style="font:10pt Times New Roman;margin-top:0pt;margin-bottom:8pt;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin-top:0pt;margin-bottom:8pt;text-indent:36pt;text-align:justify"><b><i>Organization</i></b></p> <p style="font:10pt Times New Roman;margin-top:0pt;margin-bottom:8pt;background-color:#FFFFFF;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin-top:0pt;margin-bottom:8pt;background-color:#FFFFFF;text-align:justify">The Company was incorporated in June 2013 as Somerset Transition Corporation under the Oklahoma General Corporation Act. In September 2013, the Company was redomesticated in Maryland and changed its name to Somerset Property, Inc. In July 2017, the Company was redomesticated in Nevada and changed its name to Revival, Inc. In June 2019, the Company changed its name to Farmhouse, Inc. to reflect its new business endeavors. </p> <p style="font:10pt Times New Roman;margin-top:0pt;margin-bottom:8pt;background-color:#FFFFFF;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin-top:0pt;margin-bottom:8pt;background-color:#FFFFFF;text-align:justify">In August 2019, the Company acquired Farmhouse, Inc., a Washington corporation (“Farmhouse Washington”) as its wholly owned subsidiary (the “Acquisition”). Farmhouse Washington was formed in January 2014 and has developed a social network platform, “The WeedClub® Platform”. At the closing of the Acquisition, all of the issued and outstanding shares of common stock of Farmhouse Washington were exchanged for shares of common stock of the Company on a one-for-one basis. The financial statements of the Company are the continuation of Farmhouse Washington with the adjustment to reflect the capital structure of the Company. </p> <p style="font:10pt Times New Roman;margin-top:0pt;margin-bottom:8pt;background-color:#FFFFFF;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin-top:0pt;margin-bottom:8pt;background-color:#FFFFFF;text-align:justify">Prior to the Acquisition, in August 2017, Farmhouse Washington formed Farmhouse DTLA, Inc. (“DTLA”) in California as a wholly owned subsidiary. On April 8, 2022, DTLA was awarded a 49% equity interest in a Los Angeles based multi- licensed cannabis retail dispensary, grow, manufacturer and distributor called Los Angeles Farmers, Inc. (“LAFI”). Although ownership percentages over 20% would typically be accounted for using the equity method, the Company is accounting for this investment as an investment in equity securities due to the Company not having significant influence over LAFI. The cost of this investment was expensed during the fiscal year ended December 31, 2017 and, due to uncertainties surrounding the value of LAFI and determining any award of back profits and interest, as well as the pending litigation, no value has been reflected in our consolidated financial statements as of December 31, 2022. See Note 9.</p> <p style="font:10pt Times New Roman;margin-top:0pt;margin-bottom:8pt;background-color:#FFFFFF;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin-top:0pt;margin-bottom:8pt;text-indent:36pt;text-align:justify"><b><i>Current Operations</i></b></p> <p style="font:10pt Times New Roman;margin-top:0pt;margin-bottom:8pt;background-color:#FFFFFF;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin-top:0pt;margin-bottom:8pt;background-color:#FFFFFF;text-align:justify">The Company is a technology company with multiple cannabis related divisions and IP, including the WeedClub® Platform, the @420 Twitter handle and a Web3 division. The WeedClub® Platform is a cannabis social network platform that enables industry professionals to connect, discover products and services and scale their businesses. Within the WeedClub® Platform, members utilize an increasing set of technology-based tools for discovering professional connections and information. The Company’s @420 Twitter handle serves as a public platform to engage with cannabis enthusiasts. The Company’s Web3 division, launched in December 2021, facilitates licensing opportunities between established cannabis brands and influential digital collectible holders to launch digital collectible branded products and accessories.</p> <p style="font:10pt Times New Roman;margin-top:0pt;margin-bottom:8pt;background-color:#FFFFFF;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin-top:0pt;margin-bottom:8pt;text-indent:36pt;text-align:justify"><b><i>Going Concern and Management Plans</i></b></p> <p style="font:10pt Times New Roman;margin-top:0pt;margin-bottom:8pt;background-color:#FFFFFF;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin-top:0pt;margin-bottom:8pt;background-color:#FFFFFF;text-align:justify">The accompanying consolidated financial statements have been presented on the basis that the Company is a going concern which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. For the year ended December 31, 2022, the Company had a net loss from operations of $779,632, consisting primarily of general and administrative and legal and professional expenses. In addition, as of December 31, 2022, the Company had stockholders’ deficit of $1,583,916. In view of these matters, the recoverability of any asset amounts shown in the accompanying consolidated financial statements is dependent upon the Company’s ability to expand operations and achieve profitability from its business. These factors raise substantial doubt about the Company’s ability to continue as a going concern. These consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.</p> <p style="font:10pt Times New Roman;margin-top:0pt;margin-bottom:8pt;background-color:#FFFFFF;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin-top:0pt;margin-bottom:8pt;background-color:#FFFFFF;text-align:justify">The Company has financed its activities principally from the sale of its common stock and loans from Company officers. The Company intends to finance its future working capital needs from these sources until such time that funds provided by operations are sufficient to fund working capital requirements. Management believes that the current cash on hand, loans from Company officers and funds raised from the sale of its common stock allow the Company sufficient capital for operations and to continue as a going concern.</p> <p style="font:10pt Times New Roman;margin-top:0pt;margin-bottom:8pt;background-color:#FFFFFF;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin-top:0pt;margin-bottom:8pt;background-color:#FFFFFF;text-align:justify">In February 2022, the board of directors (“Board”) authorized an offering of up to 294,118 shares of restricted common stock at $0.85 per share, providing proceeds of up to $250,000, to be offered and sold only to investors that qualify as “accredited investors” as that term is defined in Regulation D. During the year ended December 31, 2022, the Company sold 69,900 shares of common stock under this offering for proceeds of $59,415. The offering expired on August 1, 2022. See Note 7.</p> <p style="font:10pt Times New Roman;margin-top:0pt;margin-bottom:8pt;background-color:#FFFFFF;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin-top:0pt;margin-bottom:8pt;background-color:#FFFFFF;text-align:justify">In June 2022, the Company received an unsolicited offer for $165,000, net of commission, for its domain name “blunt.com” from an unaffiliated party. Management considered this offer to be a fair arms-length price for a premium domain name and in July 2022, the Company sold the domain name. This was recorded as other income during the year ended December 31, 2022. See Note 12.</p> <p style="font:10pt Times New Roman;margin-top:0pt;margin-bottom:8pt;background-color:#FFFFFF;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin-top:0pt;margin-bottom:8pt;background-color:#FFFFFF;text-align:justify">In June 2022, the Company executed a Litigation Funding Agreement with Legalist Fund III, LP (“Legalist”), whereby Legalist provided $225,000 of funding under a Litigation Funding Agreement. See Notes 5 and 9. </p>
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-779632	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-1583916	usd
CY2022	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="font:10pt Times New Roman;margin:0;text-indent:36pt"><b><i>Financial Statement Reclassification</i></b></p> <p style="font:10pt Times New Roman;margin:0"> </p> <p style="font:10pt Times New Roman;margin:0;text-align:justify">Certain amounts from the prior year’s financial statements have been reclassified in these consolidated financial statements to conform to the current year’s classifications.</p>
CY2022	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font:10pt Times New Roman;margin:0;text-indent:36pt"><b><i>Concentrations of Credit Risk</i></b></p> <p style="font:10pt Times New Roman;margin:0;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;text-align:justify">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash as of December 31, 2022. The Company places its cash with high credit quality financial institutions. </p>
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p style="font:10pt Times New Roman;margin:0;text-indent:36pt"><b><i>Use of Estimates</i></b></p> <p style="font:10pt Times New Roman;margin:0"> </p> <p style="font:10pt Times New Roman;margin:0;text-align:justify">The preparation of these consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of these consolidated financial statements and the reported amounts of revenue and expenses for the reporting period. Actual results could differ from those estimates.</p>
CY2021	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	250	usd
CY2022	us-gaap	Revenues Revenues	10261	usd
CY2021	us-gaap	Revenues Revenues	12243	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	3806	usd
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	8000	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	7218	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	0	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	94	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	94	usd
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1178	usd
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	0.351
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	45000	usd
CY2021Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	45000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	7312	usd
CY2021Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	45000	usd
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	45000	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	50000	usd
CY2021Q4	us-gaap	Notes Payable Current NotesPayableCurrent	75030	usd
CY2022	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	32650	usd
CY2022	us-gaap	Interest Paid InterestPaid	1253	usd
CY2022Q4	fil	Due To Related Parties DueToRelatedParties	44882	usd
CY2021Q4	fil	Due To Related Parties DueToRelatedParties	158191	usd
CY2022	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	113309	usd
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	295000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	295000000	shares
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	59415	usd
CY2022	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	189582	usd
CY2022	fil	Common Stock Issued For Restricted Stock Awards Shares CommonStockIssuedForRestrictedStockAwardsShares	1118000	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	17075950	shares
CY2021	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	127500	usd
CY2021	fil	Common Stock Issued For Restricted Stock Awards Shares CommonStockIssuedForRestrictedStockAwardsShares	200000	shares
CY2021	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	345768	usd
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	15694550	shares
CY2020Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Number Of Shares Period Increase Decrease SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfSharesPeriodIncreaseDecrease	0	shares
CY2020Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	0
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Number Of Shares Period Increase Decrease SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfSharesPeriodIncreaseDecrease	-200000	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.020
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	50000	shares
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	1.020
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	150000	shares
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	1.020
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Number Of Shares Period Increase Decrease SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfSharesPeriodIncreaseDecrease	-1118000	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.194
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	516000	shares
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	752000	shares
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	0.251
CY2022	fil	Stock Based Compensation On Rsa S Vested StockBasedCompensationOnRsaSVested	181112	usd
CY2021	fil	Stock Based Compensation On Rsa S Vested StockBasedCompensationOnRsaSVested	51000	usd
CY2022Q4	fil	Unrecognized Stock Based Compensation Expense UnrecognizedStockBasedCompensationExpense	188424	usd
CY2022Q4	fil	Unrecognized Stock Based Compensation Expense UnrecognizedStockBasedCompensationExpense	188424	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	737300	usd
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	904200	usd
CY2022	fil	Deferred Tax Assets Accrued Payroll DeferredTaxAssetsAccruedPayroll	184300	usd
CY2021	fil	Deferred Tax Assets Accrued Payroll DeferredTaxAssetsAccruedPayroll	184000	usd
CY2022	fil	Deferred Tax Assets Depreciation DeferredTaxAssetsDepreciation	52000	usd
CY2021	fil	Deferred Tax Assets Depreciation DeferredTaxAssetsDepreciation	98700	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	973600	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	1186900	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	usd
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	usd
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-93000	usd
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-204900	usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense Depreciation IncomeTaxReconciliationNondeductibleExpenseDepreciation	-5600	usd
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense Depreciation IncomeTaxReconciliationNondeductibleExpenseDepreciation	-6300	usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense Meals And Entertainment IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment	200	usd
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense Meals And Entertainment IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment	0	usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	77800	usd
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	83300	usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	35700	usd
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	35700	usd
CY2022	fil	Excess Book Gain On Disposal Over Tax ExcessBookGainOnDisposalOverTax	-22100	usd
CY2021	fil	Excess Book Gain On Disposal Over Tax ExcessBookGainOnDisposalOverTax	0	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	7000	usd
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	92200	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	3511000	usd
CY2022Q4	fil	Due To Related Parties DueToRelatedParties	44882	usd
CY2021Q4	fil	Due To Related Parties DueToRelatedParties	158191	usd
CY2022	us-gaap	Proceeds From Sales Of Assets Investing Activities ProceedsFromSalesOfAssetsInvestingActivities	165000	usd
CY2022	us-gaap	Net Investment Income NetInvestmentIncome	225000	usd

Files In Submission

Name	View Source	Status
0001096906-23-000882-index-headers.html	Edgar Link	pending
0001096906-23-000882-index.html	Edgar Link	pending
0001096906-23-000882.txt	Edgar Link	pending
0001096906-23-000882-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
fmhs-20221231.htm	Edgar Link	pending
fmhs-20221231.xsd	Edgar Link	pending
fmhs_ex31z1.htm	Edgar Link	pending
fmhs_ex31z2.htm	Edgar Link	pending
fmhs_ex32z1.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
fmhs-20221231_cal.xml	Edgar Link	unprocessable
fmhs-20221231_def.xml	Edgar Link	unprocessable
fmhs-20221231_lab.xml	Edgar Link	unprocessable
fmhs-20221231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
fmhs-20221231_htm.xml	Edgar Link	completed
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$FMHS
FARMHOUSE, INC. /NV Stock $fmhs

2023 Q2 Form 10-K Financial Statement

#000109690623000882 Filed on April 20, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FMHS FARMHOUSE, INC. /NV Stock $fmhs

2023 Q2 Form 10-K Financial Statement

#000109690623000882 Filed on April 20, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FMHS
FARMHOUSE, INC. /NV Stock $fmhs